First and foremost I am a clinician and surgeon with a particular expertise and passion for the treatment of patients with prostate cancer and benign prostate conditions. I do this in three ways: firstly as your doctor or surgeon, secondly through the research I perform with my highly skilled team and thirdly by offering a comprehensive second opinion service. My […]
Prof Stricker presentaion on focal therapies at UCLA. Throughout October Prof Stricker was invited to give talks in America and Canada. At UCLA he presented a slideshow on focal therapies for prostate cancer with a deeper look at irreversible electroporation (IRE) and the NanoKnife procedure. The complete presentation can be seen here: Focal Therapies for
NanoKnife© IRE – UCLA Presentation Read More »
NanoKnife© IRE Results We have now treated 450 patients since February 2013. All patients have been meticulously followed up (100% follow up) with high-quality MRIs and biopsies, in addition to being offered validated quality of life questionnaires. Our current outcomes for focal irreversible electroporation in the primary setting (not after radiotherapy) is: We are currently conducting
Focal Irreversible Electroporation Read More »
Professor Stricker was recently an invited presenter at the World Society of Robotic Surgery virtual conference (SRS Vitual Conference 2020) on salvage robotic surgery.
Salvage Robotic Surgery Presentation At SRS Read More »
Professor Stricker is currently the world’s most experienced focal nanoknife surgeon, having performed over 600 cases since 2013. He has modified and perfected his technique for select patients with prostate cancer. His nanoknife outcomes have been published in over 30 international peer reviewed papers. The most recent papers published in the British Journal of Urology International have
Nanoknife – Focal Irreversible Electroporation (IRE) Read More »
Focal therapy for selective patients with prostate cancer is a relatively new treatment for a select group of patients for the treatment of localised prostate cancer. The treatment is recommended for patients with localised prostate cancer stage T1 and T2 who are not candidates for prostatectomy because of their age, their general state of being
PSMA PET scanning is a relatively new diagnostic technology that greatly assists in localising the extent of prostate cancer. It can do this not only in the area of the prostate but also in the lymph glands and bones. As a result, therapy can be targeted more appropriately. PSMA PET/CT scanning is much more accurate
PSMA PET/CT Scanning Read More »
Recent developments in magnetic resonance imaging (MRI) have improved the ability of MRI to detect tumours, stage cancer and help in management decisions. They are also helping to more accurately target biopsies. What has changed in MRI imaging to make it so accurate? MRI has advanced recently so that not only can we look at
Multiparametric MRI Read More »
Benign prostatic enlargement is the non-cancerous enlargement of the prostate. It refers to benign prostatic hyperplasia (increase in the number of cells) or hypertrophy (increase in cell size). Benign prostatic enlargement is the most common prostate disease in men. Typically, the prostate grows to the size of a walnut, but may begin to grow again
Benign Prostatic Enlargement Read More »
Cystoscopy is an endoscopic procedure where a tube is inserted into the urethra through the opening at the end of the penis. It allows me to visually examine the complete length of the urethra and the bladder for polyps, strictures, abnormal growths and other problems. Why is the test is performed? How does the test
Recently we reviewed a group of patients that I had treated between 1998 and 2000. We followed the patients up for a minimum of 10 years and compared it to a similar surgical series. Results were outstanding and in truth out-performed my surgical results in the very high-risk population by about 20% ( these results
High-dose rate brachytherapy Read More »
I continue to perform open radical prostatectomy in several situations. Firstly, where robotic prostatectomy is difficult to perform, such as a patient who has extensive adhesions. Robotic is also not the best option where the cancer is extremely extensive and tactile sensation is beneficial. Having performed over 3,500 open radical prostatectomies I have noticed that,
Open Surgery Results Read More »
There is no excerpt because this is a protected post.
Protected: Robotic Surgery Preview Read More »
Experience I have performed over 2800 robot-assisted radical prostatectomies which is the most in the state of New South Wales and the second most in Australia. I perform approximately 200 cases per year. In addition to this, I performed over 4000 open radical prostatectomies. I have had no major complications from my technique of robotic
{mosmap width =’644’|height =’360’|align=’bottom’|sv=’bottom’|lat=’-33.880946’|lon=’151.219201’|svyaw=’150.69’|svzoom=’0’|svpitch=’-4.38’|lightbox=’0’| zoom=’16’|zoomType=’Large’|zoomNew=’0’|mapType=’Normal’|showMaptype=’0’| overview=’0’|marker=’1’|text='<div style=width:268px;height:80px;>Suite 1001, St Vincent’s Clinic<br />438 Victoria Street, Darlinghurst, NSW 2010<br />Australia </div>’}’
